Generation of an antitumour immune response to a murine mesothelioma cell line by the transfection of allogeneic mhc genes
- 15 October 1994
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 59 (2) , 212-216
- https://doi.org/10.1002/ijc.2910590213
Abstract
We have determined whether transfection and expression of allogeneic MHC genes in a murine mesothelioma cell line can generate an anti-tumour immune response. The MHC genes encoding H-2Kb and H-2Dd were transfected into the mesothelioma cell line AC29 (derived from CBA mice, H-2k) and transfectant clones isolated. Each of five H-2Kb and 4 H-2Dd transfectant clones were unable to form tumours in CBA mice, although they had maintained their ability to form tumours in F1 crosses of CBA ± C57b1/10 or CBA ± BALB/c, respectively. Thus the tumours expressing the transfected MHC genes were rejected only in an allogeneic setting. Mice without tumours after transfectant challenge were inoculated on the opposite flank with 1 ± 106 parental AC29. There was no evidence of systemic immunity to the parental cell line since tumours formed at the same rate as in naive mice. The mixing of allogeneic MHC transfectants with parental AC29 did, however, retard the growth of parental tumour. Our study illustrates that the expression of allogeneic MHC molecules on a highly immunosuppressive and non-immunogenic murine malignant mesothelioma cell line was able to stimulate rejection of tumour cells but was incapable of generating a systemic protective response against the parental cell line.Keywords
This publication has 15 references indexed in Scilit:
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- New strategies for active immunotherapy with genetically engineered tumor cellsCurrent Opinion in Immunology, 1992
- Establishment of a murine model of malignant mesotheliomaInternational Journal of Cancer, 1992
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4Cell, 1992
- HLA Antigen Expression and Malignant MesotheliomaAmerican Journal of Respiratory Cell and Molecular Biology, 1991
- Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusionsInternational Journal of Cancer, 1991
- Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor CellsPublished by Elsevier ,1991
- Role of the Major Histocompatibility Complex Class I Antigens in Tumor Growth and MetastasisAnnual Review of Immunology, 1988
- Allogeneic H-2 antigen expression is insufficient for tumor rejection.Proceedings of the National Academy of Sciences, 1987
- Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.Proceedings of the National Academy of Sciences, 1987